DOI: https://doi.org/10.22141/2224-0721.0.2.42.2012.176858

Effectiveness of Actovegin at Peripheral Angiopathy of Different Stages in Patients with Diabetes Mellitus

M.B. Gorobeiko, O.S. Larin, Ye.V. Taran

Abstract


There was assessed the effectiveness of Actovegin use at peripheral angiopathy of different stages in patients with diabetes mellitus. The assessment was carried out on principles of evidence-based medicine, using PEDIS classification. Levels of ТсРО2 were studied in patients with critical, non-critical ischemia and in control group, as well as dynamics of lower-extremity ulcers repair in patients before treatment, in 10, 45 days, 3 and 6 months and after second course of treatment. Actovegin was prescribed intravenously 2000 mg once daily during 12 days, then orally 600 mg daily up to 45 days. 39 patients were enrolled in the study, they received 2 courses of treatment, and control group — 11 patients. Treatment with Actovegin have shown efficacy in patients with diabetic foot syndrome with non-critical lower-limb ischemia: oxygen partial pressure significantly increased in lower-limb tissues both at first and second course of treatment: 35.70 ± 4,31 mmHg to 39.77 ± 8,22 mmHg in controls; 35.58 ± 6.91 mmHg to 42.37±6.22 mmHg after first course of treatment and from 36.28 ± 5.23 mmHg to 47.11 ± 6.21 mmHg after second course of treatment. This leads by-turn to more fast ulcer repair as compared to control group (p < 0.05 between controls and investigation groups). Secondary course of treatment with Actovegin significantly increased the number of repaired ulcers (after first course of treatment constant regeneration was observed in 19 (48.7 %) patients, after second course of treatment ulcers repaired in 8 patients, active epithelialization was observed in 6 patients, it means that effect of refresher course of treatment in relation to regeneration is 84.6 %). Even after decrease of oxygen partial pressure in tissues in Actovegin group there was remained positive effect in relation to wound healing and reduction of relapses number.
There was defined the significant increase of ТсРО2 in patients managed with Actovegin in group of non-critical ischemia from 10th day from initiation of treatment with retention of statistically significant effect within 3 months. Long-term effect (up 6 months) for wound healing had been proved. The efficacy of Actovegin in combined treatment of patients with critical lower-limb ischemia was defined.


References


Saint Vincent Declaration: A meeting organized by WHO and IDF in Europe. — Italy: Saint Vicent, 1989, October, 10–12.

Практичні рекомендації з лікування та профілактики синдрому діабетичної стопи — підготовлено Міжнародною робочою групою з проблеми діабетичної стопи. — Київ, 2004. — 16 с.

Міжнародна угода з проблеми діабетичної стопи. — Київ, 2004. — 96 с.

Consensus Development Conference on Diabetic Foot Wound Care — American Diabetes Association // Diabetes Care. — 1999. — Vol. 22, № 8. — Р. 1354-1360.

Горобейко М.Б., Гирявенко О.Я. Класифікація діабетичної стопи, затверджена Міжнародною робочою групою з діабетичної стопи IDF та ВООЗ // Клінічна ендокринологія та ендокринна хірургія. — 2004. — № 1 (6). — С. 83-87.

Ефимов А., Болгарская С. Синдром диабетической стопы. Эпидемиология, патогенез, клиника, диагностика, лечение трофических поражений нижних конечностей у больных сахарным диабетом // Ліки України. — 2005. — № 5. — С. 45-52.

Котов С.В., Калинин А.Л., Рудакова И.Г. Диабетическая нейропатия. — М., 2000. — 39 с.

Goodman G.R., Tersigni S., Ke Li, Lawrence P.F. Trombolytic therapy in an isolated limb // Annals of Vascular Surgery. — 1993. — Vol. 7. — Р. 512-520.

Bohme H. Die konservative therapie der chronischen peripheren arteriellen verschlusskrankheit // Chirurgische Gastroenterologie. — 1992. — Vol. 8 (Suppl. 1). — Р. 76-80.

Компендиум 2003 — лекарственные препараты / Под ред. В.Н. Коваленко, А.П. Викторова. — K.: Морион, 2003. — 1388 с.

Diagnostik und Therapie des diabetischen Fusses / M. Weck. — Kreischa, 2002. — 67 p.






Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2019

 

   Seo анализ сайта